20248-64-0

Basic information

• Product Name: 4,6-Dichloro-1,3-phenylenediamine
• Synonyms: 1,5-Diamino-2,4-dichlorobenzene;4,6-Dichloro-1,3-phenylenediamine;(5-amino-2,4-dichloro-phenyl)amine;4,6-dichlorobenzene-1,3-diamine;1,3-Benzenediamine,4,6-dichloro-
• CAS NO: 20248-64-0
• Molecular Formula: C₆H₆Cl₂N₂
• Molecular Weight: 177.03
• Mol File: 20248-64-0.mol

Chemical Properties

• Melting Point: 138-139 °C
• Boiling Point: 313.2 °C at 760 mmHg
• Flash Point: 143.2 °C
• Appearance: /
• Density: 1.501 g/cm³
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.30±0.10(Predicted)
• CAS DataBase Reference: 4,6-Dichloro-1,3-phenylenediamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-Dichloro-1,3-phenylenediamine(20248-64-0)
• EPA Substance Registry System: 4,6-Dichloro-1,3-phenylenediamine(20248-64-0)

Safety Data

• Hazardous Substances Data: 20248-64-0(Hazardous Substances Data)

Usage

Uses

Used in Hair Dye Industry:
4,6-Dichloro-1,3-phenylenediamine is used as a hair dye component for its ability to produce a range of colors when mixed with other ingredients. It is particularly effective in creating darker shades and is often used in combination with other chemicals to achieve the desired color.
Used in Rubber Industry:
4,6-Dichloro-1,3-phenylenediamine is used as a component in the production of black rubber. Its chemical properties contribute to the strength and durability of the rubber, making it suitable for various applications, such as tires and other rubber products.

Upstream product

• 1061716-31-1 N,N'-(4,6-dichloro-m-phenylene)-bis-acetamide 
• 10268-78-7 1,3-diacetylaminobenzene 
• 3698-83-7 2,4-dichloro-1,5-dinitrobenzene 

Downstream Products

• 5926-53-4 4,6-dichloro-m-phenylene diisocyanate 
• 95-94-3 1,2,4,5-tetrachlorobenzene 
• 53882-23-8 Diethyl (4,6-dichloro-m-phenylene)dioxamate 
• 3698-83-7 2,4-dichloro-1,5-dinitrobenzene 
• 252265-68-2 1,5-dichloro-2,4-dinitrosobenzene 
• 259092-66-5 2-bromo-4,6-dichloro-1,3-phenylenediamine 
• 69132-90-7 N-(3-amino-4,6-dichlorophenyl)-γ-chlorobutyramide 
• 1353989-08-8 dimethyl 5-amino-6,8-dichloro-4-hydroxy-1,2,3,4-tetrahydroquinoline-2,4-dicarboxylate 
• 1353989-21-5 N-benzyl-6,8-dichloro-1-methyl-2-oxo-1,2-dihydropyrrolo[4,3,2-d,e]quinoline-4-carboxamide 
• 916052-26-1 N-(2,4-dichloro-5-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)cyclobutanecarboxamide 
• 916052-28-3 N-{2,4-dichloro-5-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]phenyl}cyclobutanecarboxamide 
• 53882-22-7 N,N'-(4,6-Dichloro-m-phenylene)dioxamic acid 
• 259092-71-2 4-bromo-2,6-bis(tert-butyl-NNO-azoxy)-5-chloro-1,3-phenylenediamine 
• 252265-74-0 2-bromo-4,6-bis(tert-butyl-NNO-azoxy)-1,3-phenylenediamine 

Relevant articles and documents

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2

A variety of ammosamide B analogues have been synthesized and evaluated as inhibitors of quinone reductase 2 (QR2). The potencies of the resulting series of QR2 inhibitors range from 4.1 to 25,200 nM. The data provide insight into the structural parameters necessary for QR2 inhibitory activity. The natural product ammosamide B proved to be a potent QR2 inhibitor, and the potencies of the analogues generally decreased as their structures became more distinct from that of ammosamide B. Methylation of the 8-amino group of ammosamide B was an exception, resulting in an increase in quinone reductase 2 inhibitory activity from an IC50 of 61 nM to IC50 4.1 nM.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

NOVEL CHEMICAL COMPOUNDS

This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.

Novel N-phenyl-substituted N-heterocyclic compounds, their preparation and use in agents for regulating plant growth

The present invention relates to novel active compounds having a plant growth-inhibiting and herbicidal action and their preparation and to agents containing these active ingredients, and their use. The novel active compounds are saturated and unsaturated 4-membered to 7-membered ring nitrogen heterocyclic compounds which are substituted on the nitrogen atom by a phenyl radical which itself carries a trifluoromethanesulphonamido group -NH-SO2 -CF3 as a substituent. The phenyl radical can also carry other substituents and the heterocyclic structure can also be substituted. Oxo derivatives of the heterocyclic compound, in which the oxo group is preferably adjacent to the nitrogen atom, form a preferred sub-group of compounds.

N-Phenyl-substituted N-heterocyclic compounds, their preparation and use in agents for regulating plant growth

The present invention relates to novel active compounds having a plant growth-inhibiting and herbicidal action and their preparation and to agents containing these active ingredients, and their use. The novel active compounds are saturated and unsaturated 4-membered to 7-membered ring nitrogen heterocyclic compounds which are substituted on the nitrogen atom by a phenyl radical which itself carries a trifluoromethanesulphonamido group --NH--SO2 --CF3 as a substituent. The phenyl radical can also carry other substituents and the heterocyclic structure can also be substituted. Oxo derivatives of the heterocyclic compound, in which the oxo group is preferably adjacent to the nitrogen atom, form a preferred sub-group of compounds.

Cyano phenylene dioxamic molecules

Compounds represented below SPC1 And pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.